CD19-targeting CAR T cell therapy in five patients with syst…
Established
13
Citations27
Refs2025
Year
Search Works
Work Details
- DOI 10.1016/j.ero.2025.03.005
- PMID https://pubmed.ncbi.nlm.nih.gov/42540156
- PMCID https://www.ncbi.nlm.nih.gov/pmc/articles/13425174
- OpenAlex ID W4409567429
- Type Article
- Language EN
- Published 18 Apr 2025
- Volume 2 (2)
- Pages 100008
- Source EULAR Rheumatology Open
- Publisher Elsevier BV
- FWCI 8.64
- Countries 1
- Institutions 1
- Added 18 Apr 2025
- Updated 29 Oct 2026
External Links
MENU
0
CD19-targeting CAR T cell therapy in five patients with systemic sclerosis unsuitable for autologous stem cell transplantation
Article 2025 EN Gold
Objectives: The efficacy of chimeric antigen receptor (CAR) T cell therapy in patients with systemic sclerosis (SSc) has been substantiated by a small number of case reports and series. An established treatment option for severe SSc is autologous stem cell transplantation (HSCT). The objective of this analysis was to assess the feasibility and safety of CD19-targeting CAR T cell therapy in patient…
13
Citations
27
References
7
Authors
8.64
FWCI
Citations by Year
Last 2 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
7 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Ann‐Christin Pecher | Universitätsklinikum Tübingen (DE) | |
| 2 | Luca Hensen | Universitätsklinikum Tübingen (DE) | |
| 3 | Rebekka Schairer | Universitätsklinikum Tübingen (DE) | |
| 4 | Reinhild Klein | Universitätsklinikum Tübingen (DE) | |
| 5 | Wolfgang Andreas Bethge | Universitätsklinikum Tübingen (DE) | |
| 6 | Claudia Lengerke | Universitätsklinikum Tübingen (DE) | |
| 7 | Jörg Henes Corresponding | Universitätsklinikum Tübingen (DE) |
Related Works
10Data: OpenAlex